Across TCGA pan-cancer cohorts, MIR548F4 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated MIR548F4 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MIR548F4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR548F4 expression acts as an unfavorable survival marker.
UCEC are the cancer types where MIR548F4 RNA most reproducibly stratifies survival.